A 20‐Year Epidemiological Study of Pneumococcal Meningitis
The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
We conducted a retrospective analysis of 55 community-acquired Streptococcus pneumoniae meningitis illnesses in Huntington, West Virginia, from 1978 to 1997. Fourteen (36.8%) of 38 adults and 2 (11.8%) of 17 children died. Serotypes 6, 23, 3, and 18 accounted for 20 (41.7%) of 48 strains available for serotyping. Of 40 strains available for antimicrobial susceptibility testing, 1 serotype 19 and 1 serotype 23 strain showed intermediate resistance and a second serotype 23 strain showed high resistance to penicillin; all three patients survived. The case-fatality rates among adults who received penicillin alone, gentamicin in combination, or vancomycin and cephalosporin together were 57.1%, 55.5%, and 60%, respectively, and among those who received chloramphenicol or a third-generation cephalosporin, they were 11.1% or nil, respectively. No child died who received chloramphenicol or vancomycin. Two (33%) of 6 children died who received a third-generation cephalosporin; both were critically ill when initially treated. No child and one adult had received pneumococcal vaccine prior to becoming ill.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite reported successes, there has been a report of cases of invasive H. influenzae type b disease in children previously vaccinated in Nottingham, United Kingdom (117), perhaps because in the United Kingdom, children are vaccinated at 2, 3, and 4 months of age without the administration of a booster dose (295).”
From Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis (2010) · cites this paper as [295]
Citations
Cites
Acute Bacterial Meningitis in Adults -- A Review of 493 Episodes
Durand, M. L., Calderwood, S. B., Weber, D. J., Miller, S. I., Southwick, F. S., Caviness, V. S., & Swartz, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280104 · Cited by 1,344 · cited 2×
“Age, an impaired level of consciousness, and seizures within the first 24 hours proved the most important prognostic factors [28].”
BackgroundOutcomes of bacterial meningitis in children: a meta-analysis
BARAFF, L. J., LEE, S. I., & SCHRIGER, D. L. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199305000-00008 · Cited by 495 · cited 4×
“These case-fatality rates do not differ from those in other industrialized populations [27-29].”
BackgroundInfluentialDoern, G. V., Brueggemann, A., Holley, H. P., & Rauch, A. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1208 · Cited by 482 · cited 1×
“resistant strains emerged also during this time period, including strains that exhibited resistance to the cephalosporin class of antibiotics [21, 40-44].”
BackgroundRennels, M. B., Edwards, K. M., Keyserling, H. L., Reisinger, K. S., Hogerman, D. A., Madore, D. V., Chang, I., Paradiso, P. R., Malinoski, F. J., & Kimura, A. (1998) · Pediatrics · doi:10.1542/peds.101.4.604 · Cited by 392 · cited 1×
“A protein conjugate vaccine currently under development appears to be highly antigenic in infants and children [50-55].”
BackgroundCost-effectiveness of Vaccination Against Pneumococcal Bacteremia Among Elderly People
Sisk, J. E. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160053038 · Cited by 362 · cited 1×
“It continues to be underused even though the cost benefit of he vaccine has been well established [49].”
BackgroundKlugman, K. P., Friedland, I. R., & Bradley, J. S. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.1988 · Cited by 240
Davidson, M., Parkinson, A. J., Bulkow, L. R., Fitzgerald, M. A., Peters, H., & Parks, D. J. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.2.368 · Cited by 231 · cited 2×
“incidence was 84 cases/100,000 [32].”
BackgroundClavo‐Sanchez, A. J., Giron‐Gonzalez, J. A., Lopez‐Prieto, D., Canueto‐Quintero, J., Sanchez‐Porto, A., Vergara‐Campos, A., Marin‐Casanova, P., & Cordoba‐Dona, J. A. (1997) · Clinical Infectious Diseases · doi:10.1086/513628 · Cited by 172
Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci
Viladrich, P. F., Gudiol, F., Liñares, J., Rufi, G., Ariza, J., & Pallarés, R. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90061-7 · Cited by 155 · cited 1×
“With the worldwide emergence of penicillin-nonsusceptible (resistant) pneumococci over the last several years, treatment regimens now include the cephalosporin class of antibiotics and vancomycin [11-13].”
BackgroundOutcomes of bacterial miningitis in children: A meta-analysis
Paik, L. (1993) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)81289-2 · Cited by 149
Research works printed but not linked: 3
- Kirkpatrick B, 1994, J Clin Microbiol, 32, 63
- Urwin G, 1991, J Clin Microbiol, 29, 14
- Rasmussen HH, 1994, Israel. Isr J Med Sci, 30, 5
Cited by
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930
“Gram staining correctly identifies the pathogen in 69 to 93% of patients with pneumococcal meningitis (11, 15, 49, 68, 95, 148, 208, 242, 286, 294, 340).”
BackgroundKastenbauer, S., & Pfister, H.-W. (2003) · Brain · doi:10.1093/brain/awg113 · Cited by 482
Pathogenesis and pathophysiology of pneumococcal meningitis
Koedel, U., Scheld, W. M., & Pfister, H.-W. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00450-4 · Cited by 380
Weisfelt, M., van de Beek, D., Spanjaard, L., Reitsma, J. B., & de Gans, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70288-x · Cited by 313
Bacteremic and Nonbacteremic Pneumococcal Pneumonia A Prospective Study
Musher, D. M., Alexandraki, I., Graviss, E. A., Yanbeiy, N., Eid, A., Inderias, L. A., Phan, H. M., & Solomon, E. (2000) · Medicine · doi:10.1097/00005792-200007000-00002 · Cited by 217
Metadata
- Authors
- Stanek, R. J., & Mufson, M. A.
- Affiliations
- Marshall University (US)
- Corresponding author
- Mufson, Maurice A.
- ORCID
- Mufson, Maurice A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-06
- Volume
- 28
- Issue
- 6
- Pages
- 1265-1272
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2137414109
- Cited by
- 59
- References
- 55
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 2
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- pneumococcal meningitis, Streptococcus pneumoniae, community-acquired meningitis, case fatality rate, serotypes, antimicrobial resistance, penicillin resistance, vancomycin, gentamicin, chloramphenicol, third-generation cephalosporins, pneumococcal vaccine, children, adults
- MeSH terms
- Adolescent, Adult, Aged, Bacterial Vaccines, Cerebrospinal Fluid Proteins, Child, Child, Preschool, Humans, Infant, Infant, Newborn, Meningitis, Pneumococcal, Microbial Sensitivity Tests, Middle Aged, Streptococcus pneumoniae, Time Factors, Incidence, Pneumococcal Vaccines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A 20‐Year Epidemiological Study of Pneumococcal Meningitis. https://app.cochat.ai/papers/10.1086/514777
- The paper
- Stanek, R. J., & Mufson, M. A. (1999). A 20‐Year Epidemiological Study of Pneumococcal Meningitis. Clinical Infectious Diseases. https://doi.org/10.1086/514777
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.